• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寄生虫磷脂诱导的嗜酸性粒细胞增多和肥大细胞增生

Eosinophilia and mast cell hyperplasia induced by parasite phospholipid.

作者信息

Archer G T, Robson J E, Thompson A R

出版信息

Pathology. 1977 Apr;9(2):137-53. doi: 10.3109/00313027709085252.

DOI:10.3109/00313027709085252
PMID:876690
Abstract

Phospholipid preparations from the nematode Ascaris suum or cysts of Echinococcus granulosus (hydatid cysts) induced an eosinophilia when injected into the peritoneal cavity of rats. Peritoneal eosinophilia persisted throughout 21 days of daily injections of Ascaris lipid and was accompanied by blood eosinophilia, mast cell granule lysis and mast cell hyperplasia. The active material consisted of lecithin and lecithin plasmalogen, and in aqueous suspension had a membrane-like appearance. Electron microscopy revealed that the phospholipid was ingested by all types of cells in the peritoneal cavity, including mast cells, and was rapidly broken down by eosinophils. Phagocytosis was found to be complement dependent. The lipid combined with properdin in human serum and stimulated complement breakdown via the alternative complement pathway.

摘要

将来自猪蛔虫的磷脂制剂或细粒棘球绦虫的囊肿(包虫囊肿)注射到大鼠腹腔内会引起嗜酸性粒细胞增多。在每天注射蛔虫脂质的21天内,腹腔嗜酸性粒细胞增多持续存在,并伴有血液嗜酸性粒细胞增多、肥大细胞颗粒溶解和肥大细胞增生。活性物质由卵磷脂和溶血卵磷脂组成,在水悬浮液中呈膜状外观。电子显微镜显示,磷脂被腹腔内的所有细胞类型摄取,包括肥大细胞,并被嗜酸性粒细胞迅速分解。发现吞噬作用依赖补体。该脂质与人血清中的备解素结合,并通过替代补体途径刺激补体分解。

相似文献

1
Eosinophilia and mast cell hyperplasia induced by parasite phospholipid.寄生虫磷脂诱导的嗜酸性粒细胞增多和肥大细胞增生
Pathology. 1977 Apr;9(2):137-53. doi: 10.3109/00313027709085252.
2
Mast cell hyperplasia and eosinophilia induced by Ascaris body fluid.蛔虫体液诱导的肥大细胞增生和嗜酸性粒细胞增多。
Br J Exp Pathol. 1971 Dec;52(6):696-702.
3
Eosinophilia induced by heparin-protamine complexes.肝素-鱼精蛋白复合物诱导的嗜酸性粒细胞增多症。
Pathology. 1973 Jul;5(3):219-27. doi: 10.3109/00313027309060838.
4
Eosinophilia, mast cell hyperplasia and antibody production in rats following an intraperitoneal injection of Ascaris cuticle including in-vitro studies of immune eosinophil granule lysis.腹腔注射蛔虫角质层后大鼠的嗜酸性粒细胞增多、肥大细胞增生及抗体产生,包括免疫嗜酸性粒细胞颗粒溶解的体外研究
Pathology. 1985 Jan;17(1):101-7. doi: 10.3109/00313028509063735.
5
Evidence for eosinophil recruitment, leukotriene B4 production and mast cell hyperplasia following Toxocara canis infection in rats.证据表明,感染犬弓首蛔虫后,大鼠嗜酸性粒细胞募集、白三烯 B4 产生和肥大细胞增生。
Braz J Med Biol Res. 2011 Apr;44(4):319-26. doi: 10.1590/s0100-879x2011007500027. Epub 2011 Mar 4.
6
Mast cell changes in rats with eosinophilia.嗜酸性粒细胞增多大鼠的肥大细胞变化
J Pathol Bacteriol. 1968 Jan;95(1):217-24. doi: 10.1002/path.1700950126.
7
Mechanism of eosinophilia and mast cell disruption in rats infected with the parasite Amplicaecum robertsi.感染罗伯茨扩大盲肠线虫的大鼠嗜酸性粒细胞增多和肥大细胞破坏的机制
Pathology. 1969 Apr;1(2):133-40. doi: 10.3109/00313026909061047.
8
Specificity of C3 receptors that mediate phagocytosis by rat peritoneal mast cells.介导大鼠腹膜肥大细胞吞噬作用的C3受体的特异性。
J Immunol. 1981 Jun;126(6):2302-6.
9
Nonatopic allergen-independent mast cell activation in parasitized eosinophilic athymic rats.寄生虫感染的嗜酸性粒细胞缺乏胸腺大鼠中与非特应性变应原无关的肥大细胞活化
Parasite Immunol. 2005 Dec;27(12):431-8. doi: 10.1111/j.1365-3024.2005.00786.x.
10
Eosinophilia in mouse regulated by multiple factors following repeated stimulations with ascaris eggs into the peritoneal cavity.在用蛔虫卵反复刺激小鼠腹腔后,嗜酸性粒细胞增多受多种因素调控。
Int Arch Allergy Appl Immunol. 1989;89(1):54-9. doi: 10.1159/000234923.

引用本文的文献

1
Hepatic echinococcosis: clinical and therapeutic aspects.肝包虫病:临床与治疗方面。
World J Gastroenterol. 2012 Apr 7;18(13):1448-58. doi: 10.3748/wjg.v18.i13.1448.
2
Concepts in immunology and diagnosis of hydatid disease.包虫病的免疫学与诊断概念
Clin Microbiol Rev. 2003 Jan;16(1):18-36. doi: 10.1128/CMR.16.1.18-36.2003.